Priscilla Brebi

Priscilla Brebi

Auto-generated profile, based on publicly available information

Priscilla Brebi

Universidad de La Frontera, School of Medicine, Department of Pathology, Molecular Pathology Laboratory, BIOREN-CEGIN, Temuco, Chile

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2012 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
KSKathleen Saavedra
Kathleen Saavedra
PBPriscilla M Brebi
Priscilla M Brebi
Juan Carlos RoaJuan Carlos Roa
Juan Carlos Roa
Cervical cancer (CC) is one of the most malignant tumors and the second or third most common type of cancer in women worldwide. The association between human papillomavirus (HPV) and CC is widely known and accepted (99.7% of cases). At present, the pathogenesis mechanisms of CC are not entirely clear. It has been shown that inactivation of tumor suppressor genes and activation of oncogenes play a significant role in carcinogenesis, caused by the genetic and epigenetic alterations. In the past, it was generally thought that genetic mutation was a key event of tumor pathogenesis, especially somatic mutation of tumor suppressor genes. With deeper understanding of tumors in recent years, increasing evidence has shown that epigenetic silencing of those genes, as a result of aberrant hypermethylation of CpG islands in promoters and histone modification, is essential to carcinogenesis and metastasis. The term epigenetics refers to heritable changes in gene expression caused by regulation mechanisms, other than changes in DNA sequence. Specific epigenetic processes include DNA methylation, chromotin remodeling, histone modification, and microRNA regulations. These alterations, in combination or individually, make it possible to establish the methylation profiles, histone modification maps, and expression profiles characteristic of this pathology, which become useful tools for screening, early detection, or prognostic markers in cervical cancer. This paper reviews recent epigenetics research progress in the CC study, and tries to depict the relationships between CC and DNA methylation, histone modification, as well as microRNA regulations.

13 July 2012 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
PLPablo Letelier
Pablo Letelier
PBPriscilla Brebi
Priscilla Brebi
OTOscar Tapia
Oscar Tapia
Juan Carlos RoaJuan Carlos Roa
Juan Carlos Roa
Gallbladder cancer is an infrequent neoplasia with noticeable geographical variations in its incidence around the world. In Chile, it is the main cause of death owing to cancer in women over 40 years old, with mortality rates up to 16.5 per 100,000 cases. The prognosis is poor with few therapeutic options; in advanced cases there is only a 10% survival at 5 years.Several studies mention the possible role of DNA methylation in gallbladder carcinogenesis. This epigenetic modification affects tumor suppressor genes involved in regulation pathways, cell cycle control, cell adhesion and extracellular matrix degradation, in a sequential and cumulative way. Determining DNA methylation patterns would allow them to be used as biomarkers for the early detection, diagnosis, prognosis and/or therapeutic selection in gallbladder cancer.

1 August 2011 in Idesia (Arica)
Verified
Journal Article
Open access
PDF file
MBM Priscilla Brebi
M Priscilla Brebi
AAAlfonso Aguilera
Alfonso Aguilera
NONelson Ojeda
Nelson Ojeda
RRRamón Rebolledo
Ramón Rebolledo